JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tortoli, E.
Right arrow Articles by Mazzarelli, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tortoli, E.
Right arrow Articles by Mazzarelli, G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2003, p. 4418-4420, Vol. 41, No. 9
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.9.4418-4420.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Evaluation of INNO-LiPA MYCOBACTERIA v2: Improved Reverse Hybridization Multiple DNA Probe Assay for Mycobacterial Identification

Enrico Tortoli,1* Alessandro Mariottini,1,2 and Gianna Mazzarelli1,3

Regional Reference Center for Mycobacteria, Microbiology and Virology Laboratory,1 Cytogenetics and Genetics Unit,2 Microbiological and Virological Serum-Immunology Laboratory, Careggi Hospital, Florence, Italy3

Received 3 March 2003/ Returned for modification 2 May 2003/ Accepted 6 June 2003

INNO-LiPA MYCOBACTERIA (Innogenetics, Ghent, Belgium) is a reverse hybridization DNA probe assay that has been recently improved by increasing the number of identifiable mycobacterial species to 16. Our assessment, performed with 197 mycobacteria belonging to 81 taxa, revealed 100% specificity and sensitivity for 20 out of 23 probes. The probes specific for Mycobacterium fortuitum complex, for the Mycobacterium avium-intracellulare-scrofulaceum group, and for Mycobacterium intracellulare type 2 cross-reacted with several mycobacteria rarely isolated from clinical specimens. The overall sensitivity was 100%, and the overall specificity was 94.4%.


* Corresponding author. Mailing address: Regional Reference Center for Mycobacteria, Piastra dei Servizi, Ospedale di Careggi, viale Morgagni 85, 50134 Florence, Italy. Phone: 39-055-4279199. Fax: 39-055-4279010. E-mail: e.tortoli{at}libero.it.


Journal of Clinical Microbiology, September 2003, p. 4418-4420, Vol. 41, No. 9
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.9.4418-4420.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.